icon_20251106140302787.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Abstract password authentication.<br>Password is required to view the abstract. Please enter a password to authenticate.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Announcements

Sessions

Profile management

Bookmark

Search presentations

Download PDF for print

Timetable

抗MTBRタウ抗体E2814の顕性遺伝アルツハイマー病におけるバイオマーカー効果

レカネマブの上市、ドナネマブの承認申請と抗Aβ薬については順調な開発が続けられている。まずはこれらの上市後の状況と市販後調査の動向、そしてそれらに続く新しい薬剤の今後の開発の方向性について議論したい。また、Aβ以外のターゲットについての創薬状況についても各開発企業担当者より最新情報を提供していただく。

Annual Meeting of Japan Society for Dementia Research

The 43rd Annual Meeting of Japan Society for Dementia Research

The 43rd Annual Meeting of Japan Society for Dementia Research

[SY1-1]抗MTBRタウ抗体E2814の顕性遺伝アルツハイマー病におけるバイオマーカー効果

Password required to view